Switch theme
Sign up to access all valuation multiples
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company’s three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
1985
1.9K+
LTM Revenue $2.3B
LTM EBITDA $174M
$1.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Astrana Health has a last 12-month revenue (LTM) of $2.3B and a last 12-month EBITDA of $174M.
In the most recent fiscal year, Astrana Health achieved revenue of $2.0B and an EBITDA of $142M.
Astrana Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Astrana Health valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $2.3B | XXX | $2.0B | XXX | XXX | XXX |
| Gross Profit | $266M | XXX | $271M | XXX | XXX | XXX |
| Gross Margin | 12% | XXX | 13% | XXX | XXX | XXX |
| EBITDA | $174M | XXX | $142M | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 7% | XXX | XXX | XXX |
| EBIT | $97.2M | XXX | $89.3M | XXX | XXX | XXX |
| EBIT Margin | 4% | XXX | 4% | XXX | XXX | XXX |
| Net Profit | $47.8M | XXX | $43.1M | XXX | XXX | XXX |
| Net Margin | 2% | XXX | 2% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $146M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Astrana Health's stock price is $25.
Astrana Health has current market cap of $1.1B, and EV of $1.3B.
See Astrana Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.3B | $1.1B | XXX | XXX | XXX | XXX | $0.99 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Astrana Health has market cap of $1.1B and EV of $1.3B.
Astrana Health's trades at 0.7x EV/Revenue multiple, and 9.4x EV/EBITDA.
Equity research analysts estimate Astrana Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Astrana Health has a P/E ratio of 23.9x.
See valuation multiples for Astrana Health and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.1B | XXX | $1.1B | XXX | XXX | XXX |
| EV (current) | $1.3B | XXX | $1.3B | XXX | XXX | XXX |
| EV/Revenue | 0.6x | XXX | 0.7x | XXX | XXX | XXX |
| EV/EBITDA | 7.7x | XXX | 9.4x | XXX | XXX | XXX |
| EV/EBIT | 13.7x | XXX | 14.9x | XXX | XXX | XXX |
| EV/Gross Profit | 5.0x | XXX | n/a | XXX | XXX | XXX |
| P/E | 23.9x | XXX | 26.5x | XXX | XXX | XXX |
| EV/FCF | 169.9x | XXX | 30.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAstrana Health's last 12 month revenue growth is 21%
Astrana Health's revenue per employee in the last FY averaged $1.1M, while opex per employee averaged $0.1M for the same period.
Astrana Health's rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Astrana Health's rule of X is 60% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Astrana Health and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 21% | XXX | 20% | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Growth | 14% | XXX | 21% | XXX | XXX | XXX |
| Rule of 40 | 30% | XXX | 28% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 60% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $1.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 9% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Astrana Health acquired XXX companies to date.
Last acquisition by Astrana Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Astrana Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Astrana Health founded? | Astrana Health was founded in 1985. |
| Where is Astrana Health headquartered? | Astrana Health is headquartered in United States of America. |
| How many employees does Astrana Health have? | As of today, Astrana Health has 1.9K+ employees. |
| Who is the CEO of Astrana Health? | Astrana Health's CEO is Mr. Brandon K. Sim, M.S.. |
| Is Astrana Health publicy listed? | Yes, Astrana Health is a public company listed on NAS. |
| What is the stock symbol of Astrana Health? | Astrana Health trades under ASTH ticker. |
| When did Astrana Health go public? | Astrana Health went public in 2015. |
| Who are competitors of Astrana Health? | Similar companies to Astrana Health include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Astrana Health? | Astrana Health's current market cap is $1.1B |
| What is the current revenue of Astrana Health? | Astrana Health's last 12 months revenue is $2.3B. |
| What is the current revenue growth of Astrana Health? | Astrana Health revenue growth (NTM/LTM) is 21%. |
| What is the current EV/Revenue multiple of Astrana Health? | Current revenue multiple of Astrana Health is 0.6x. |
| Is Astrana Health profitable? | Yes, Astrana Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Astrana Health? | Astrana Health's last 12 months EBITDA is $174M. |
| What is Astrana Health's EBITDA margin? | Astrana Health's last 12 months EBITDA margin is 8%. |
| What is the current EV/EBITDA multiple of Astrana Health? | Current EBITDA multiple of Astrana Health is 7.7x. |
| What is the current FCF of Astrana Health? | Astrana Health's last 12 months FCF is $7.9M. |
| What is Astrana Health's FCF margin? | Astrana Health's last 12 months FCF margin is 0%. |
| What is the current EV/FCF multiple of Astrana Health? | Current FCF multiple of Astrana Health is 169.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
